When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Alzheimer's Disease Neuroimaging Initiative - Wikipedia

   en.wikipedia.org/wiki/Alzheimer's_Disease...

   Alzheimer's Disease Neuroimaging Initiative (ADNI) is a multisite study that aims to improve clinical trials for the prevention and treatment of Alzheimer's disease (AD). [1] This cooperative study combines expertise and funding from the private and public sector to study subjects with AD, as well as those who may develop AD and controls with ...

3. List of clinical trial registries - Wikipedia

   en.wikipedia.org/wiki/List_of_clinical_trial...

   The DRKS is an open access, free of charge online register for clinical trials and is available both in English and German. DRKS is part of the WHO's ICTRP. The DRKS works with two partner registries in Germany, DeReG (German Registry for Somatic Gene-Transfer Trials) and Clinical Trial Registry of the University Medical Center Freiburg. [4]

4. Alzheimer's Drug Discovery Foundation - Wikipedia

   en.wikipedia.org/wiki/Alzheimer's_Drug_Discovery...

   Through PACT, the ADDF is funding a number of "repurposing" [18] clinical trials, whereby drugs developed for other indications (e.g., diabetes) are tested for their effectiveness in Alzheimer's disease. Because these drugs have already passed significant safety tests, the risk of failure is reduced and, if pharmaceuticals are found to be ...

5. ClinicalTrials.gov - Wikipedia

   en.wikipedia.org/wiki/ClinicalTrials.gov

   The Food and Drug Administration Modernization Act of 1997 (Public Act 105-115) [4] amended the Food, Drug and Cosmetic Act and the Public Health Service Act to require that the NIH create and operate a public information resource, which came to be called ClinicalTrials.gov, tracking drug efficacy studies resulting from approved Investigational ...

6. Scientist behind Alzheimer’s drug in late-stage trials is ...

   www.aol.com/news/scientist-behind-alzheimer-drug...

   The drug is currently in a late-stage clinical trial, and some 735 patients had participated as of May 2024, according to a news release from Cassava last month. Wang did not immediately respond ...

7. The most promising breakthrough in Alzheimer’s treatment is ...

   www.aol.com/news/most-promising-breakthrough...

   The devastation of failed Alzheimer's drug trials is requiring people to open their minds to new approaches, methods, and disciplines. The most promising breakthrough in Alzheimer’s treatment is ...

8. Metformin - Wikipedia

   en.wikipedia.org/wiki/Metformin

   Preliminary studies have examined whether metformin can reduce the risk of Alzheimer's disease and whether there is a correlation between type 2 diabetes and the risk of Alzheimer's disease. [248] [249] While metformin may reduce body weight in persons with fragile X syndrome, whether it improves neurological or psychiatric symptoms is uncertain.

9. US professor charged with manipulating data for Alzheimer’s ...

   www.aol.com/news/us-professor-charged...

   (Reuters) -A U.S. medical professor has been charged with fraud for allegedly submitting false data to get millions of dollars in public funds for research into a drug to treat Alzheimer’s disease.